Analysis

Imunon, Inc. (IMNN) Stock Analysis

Imunon, Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to IMNN.

websiteIMNN/analysis/IMNN

Imunon, Inc.

Imunon, Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to IMNN.

Stock profile

Ticker

IMNN

Asset type

Stock

Market cap

$7.6M

Sector

Health Technology

Industry

Biotechnology

Currency

USD

Ticker listings

Imunon, Inc. may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.

  • IMNN primary listing
  • A41CNR
  • CBO0
  • 0HUZ

Latest Imunon, Inc. news

IMUNON to Present at the Life Sciences Investor Forum on June 25th

LAWRENCEVILLE, N.J., June 22, 2026 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage company in Phase 3 development with its DNA-mediated immunotherapy, today an...

IMUNON Announces Up to $10 Million Cash Financing

IMUNON Announces Up to $10 Million Cash Financing

IMUNON Reports First Quarter 2026 Financial Results and Provides Business Update

IMNN-001 is the First and Only frontline treatment candidate to demonstrate the potential for a clinically meaningful overall survival benefit in women newly diagnosed with ovar...

IMUNON to Hold First Quarter 2026 Financial Results and Business Update Conference Call on Tuesday, May 12, 2026

LAWRENCEVILLE, N.J., May 05, 2026 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage company in late-stage development with its DNA-mediated immunotherapy, announ...

IMUNON Reports 2025 Financial Results and Provides Business Update Highlighting Significant Progress with Pivotal Phase 3 Study

IMNN-001 is the first frontline immunotherapy to demonstrate the potential for a clinically meaningful overall survival benefit in women newly diagnosed with

Research sections

Valuation

Review valuation context for Imunon, Inc..

Future growth

Review future growth context for Imunon, Inc..

Past performance

Review past performance context for Imunon, Inc..

Financial health

Review financial health context for Imunon, Inc..

Dividend

Review dividend context for Imunon, Inc..

Management

Review management context for Imunon, Inc..

Ownership

Review ownership context for Imunon, Inc..

Other information

Review other information context for Imunon, Inc..

Community

Review community context for Imunon, Inc..